NASDAQ: LIMNLiminatus Pharma Inc Stock Ownership - Who owns Liminatus Pharma?
Insider buying vs selling
Have Liminatus Pharma Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when LIMN insiders and whales buy or sell their stock.
LIMN Shareholders
What type of owners hold Liminatus Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Iris Acquisition Holdings LLC | 25.49% | 6,900,000 | $1.39M | Insider |
| Chris Kim | 22.80% | 6,169,406 | $1.24M | Insider |
| Valetudo Therapeutics LLC | 22.80% | 6,169,406 | $1.24M | Insider |
| Kh Feelux Co Ltd | 14.78% | 4,000,000 | $804.00k | Insider |
| Vanguard Group Inc | 0.27% | 73,424 | $14.76k | Institution |
| Citadel Advisors LLC | 0.26% | 70,930 | $14.26k | Institution |
| Geode Capital Management LLC | 0.24% | 65,051 | $13.08k | Institution |
| Two Sigma Investments LP | 0.13% | 35,284 | $7.09k | Institution |
| Ubs Group Ag | 0.07% | 19,395 | $3.90k | Institution |
| State Street Corp | 0.07% | 19,000 | $3.82k | Institution |
LIMN vs Biotech Stocks
Liminatus Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.